AKST-4290

N/A

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameAKST-4290
Drug Alias NameALK-4290AKST-4290BI-144807
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 3 antagonists
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsPemphigoid, BullousWet age-related macular degenerationMacular Degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSlovakiaPoland +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesAlkahest Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsPemphigoid, BullousWet age-related macular degenerationDiabetic Retinopathy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A